Granulocyte colony‐stimulating factor administration upregulates telomerase activity in CD34+ haematopoietic cells and may prevent telomere attrition after chemotherapy
Open Access
- 24 January 2003
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 120 (2) , 329-336
- https://doi.org/10.1046/j.1365-2141.2003.04043.x
Abstract
Summary. Hematopoietic reconstitution could be associated with premature ageing of the transplanted cells and a high frequency of myelodysplastic syndrome and secondary leukaemia. Telomere length decreases with cell divisions and age, and at a crucial length it is associated with chromosomal instability and cell senescence. Telomerase is a reverse transcriptase enzyme that adds nucleotides to chromosomal ends. Most somatic cells lack telomerase activity yet haematopoietic stem cells retain low levels of telomerase. Some studies have found that chemotherapy and stem cell transplantation lead to the accelerated shortening of telomere length. As granulocyte colony‐stimulating factor (G‐CSF) is routinely used in the mobilization of stem cells for transplantation, we evaluated its effects on telomerase activity and regulation, and on telomere dynamics, in normal donors and selected lymphoma patients. Administration of G‐CSF increased telomerase activity in CD34+ haematopoietic cells compared with controls. In marrow‐derived CD34+ cells, telomerase activity increased sevenfold, compared with a 14‐fold increase in peripheral‐blood‐mobilized CD34+ cells. A parallel increase in the expression of human telomerase enzyme reverse transcriptase RNA and protein kinase C α occurred. In addition, G‐CSF administration to five lymphoma patients after consecutive courses of CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy, resulted in telomere length preservation or elongation, as opposed to marked attrition in patients who did not receive growth factors. We conclude that the in vivo administration of G‐CSF prevents or attenuates telomere attrition associated with chemotherapy administration. This attenuation may contribute to the preservation of telomere integrity inG‐CSF‐primed transplanted stem cells.Keywords
This publication has 48 references indexed in Scilit:
- Telomerase is regulated by protein kinase C-ζ in human nasopharyngeal cancer cellsBiochemical Journal, 2001
- Granulocyte Colony-stimulating Factor Induces Erk5 Activation, Which Is Differentially Regulated by Protein-tyrosine Kinases and Protein Kinase CPublished by Elsevier ,2001
- Shortening of telomeres in recipients of both autologous and allogeneic hematopoietic stem cell transplantationBone Marrow Transplantation, 2000
- Differential Expression of Protein Kinase C Isoform Transcripts in Human Hematopoietic Progenitors Undergoing DifferentiationBiochemical and Biophysical Research Communications, 1999
- In Vivo and in Vitro Analyses of Myc for Differential Promoter Activities of the Human Telomerase (hTERT) Gene in Normal and Tumor CellsBiochemical and Biophysical Research Communications, 1999
- Telomere length changes in patients undergoing hematopoietic stem cell transplantationBone Marrow Transplantation, 1999
- Changes of telomere length in children after hematopoietic stem cell transplantationBone Marrow Transplantation, 1998
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- Telomeres shorten during ageing of human fibroblastsNature, 1990
- Secondary Cancers after Bone Marrow Transplantation for Leukemia or Aplastic AnemiaNew England Journal of Medicine, 1989